Search results
Results from the WOW.Com Content Network
Biotechnology in India is a sunrise sector within the Indian economy. [1] Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. [2]
The top five companies were homegrown; Indian firms account for 72% of the bio-pharma sector and 52% of the industry as a whole.[4,46] The Association of Biotechnology-Led Enterprises (ABLE) is aiming to grow the industry to $5 billion in revenues generated by 1 million employees by 2009, and data from the Confederation of Indian Industry (CII ...
Among continents, European countries sold the highest dollar value worth of exported drugs and medicines during 2018 with shipments from Europe totaling $295.8 billion or 79.70% of the global total. In second place were Asian pharmaceutical exporters at 10.70% while 8.10% of worldwide drugs and medicine shipments originated from North America.
Biotechnology in India (2 C, 14 P) S. ... List of countries by stem cell research trials; B. Biotechnology and genetic engineering in Bangladesh; N.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
However, according to former Indian science and technology minister Kapil Sibal, India is lagging in science and technology compared to developed countries. [4] India has only 140 researchers per 1,000,000 population, compared to 4,651 in the United States. [4] India invested US$3.7 billion in science and technology in 2002–2003. [5]
Biotechnology companies of the United Kingdom (31 P) Biotechnology companies of the United States (6 C, 331 P) Pages in category "Biotechnology companies by country"
Lupin's businesses encompass the entire pharmaceutical value chain, ranging from branded and generic formulations, APIs, advanced drug delivery systems to biotechnology. . The company's drugs reach 70 countries [22] with a footprint that covers advanced markets such as USA, Europe, Japan, [23] Australia as well as emerging markets including India, the Philippines and South Africa to name a